Telix Pharmaceuticals Ltd
ASX:TLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
Chrysalis Investments Ltd
LSE:CHRY
|
GG |
|
Chocoladefabriken Lindt & Spruengli AG
OTC:COCXF
|
CH |
|
Emmi AG
SIX:EMMN
|
CH |
|
BOK Financial Corp
NASDAQ:BOKF
|
US |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
US |
|
L
|
Laurent Perrier SA
F:LPE
|
FR |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
Five Star Bancorp
NASDAQ:FSBC
|
US |
|
Ningbo Tuopu Group Co Ltd
SSE:601689
|
CN |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
Shareholder Yield
Current shareholder yield for TLX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TLX Price
Telix Pharmaceuticals Ltd
| Average Annual Return | 62.41% |
| Standard Deviation of Annual Returns | 64.53% |
| Max Drawdown | -72% |
| Market Capitalization | 4.4B AUD |
| Shares Outstanding | 339 110 000 |
| Percentage of Shares Shorted |
N/A
|
